Skip to main content
Caplight Logo









Sofya

Sofya

Private
United StatesHealthcare & Life Scienceshttps://www.sofya.ai/

Last Round

Seed

Sep 10, 2025

Total Funding Raised

$25,000

Company Overview

Sofya is a healthtech company that provides an AI-powered clinical reasoning engine designed to automate clinical documentation, structure patient data, and support medical decision-making for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, EHR & EMR, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

clinical documentationAI scribeambient scribehealthtechmedical AImedical transcriptionclinical decision supportelectronic health recordEHRclinical intelligencehealthcare LLMmedical second brainworkflow automationusage-based billingvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sofya Comparables

Compare Sofya with similar companies based on industry and business-model similarity.

Sofya comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glass Health
87%
Freed
79%
Nabla
78%

Sofya Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 10, 2025
GrantApr 8, 2025

Key People

Founding team and executive leadership

Tiago Braga Machado

Co-Founder & CTO

Founding Team

Marcelo Mearim

CEO Brazil and co-founder

Founding Team

Carlos Teixeira de Freitas

COO

Executive Team

Sofya Investors

Notable investors and investment history

Sofya investors
InvestorRounds
Johnson & Johnson FoundationGrant
Village CapitalGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 209% MoM, reaching 1.7K.

  • Nov 27, 2024

    Grew 38% QoQ, from 16 to 22 employees.

Recent news

Latest coverage and updates

  • hiresAug 13, 2026

    Sofya hired Roberto Forti as Head of Healthcare & Product on Aug 13th '26.

Sofya Filings

Explore SEC and related filing metadata, where available.

Sofya filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sofya's valuation, stock price, and market status.

Is Sofya a public or private company?

Sofya is a private company.

What is the current stock price of Sofya?

Sofya is a private company with no public stock price. No recent secondary market data is available.

How much is Sofya worth (valuation)?

Valuation information for Sofya is not publicly available.

Can I buy Sofya stock?

Sofya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sofya's last funding round?

Sofya's most recent funding round was Seed on September 10, 2025.

Who are the main investors in Sofya?

Key investors in Sofya include Johnson & Johnson Foundation, Village Capital.

Will Sofya IPO soon?

No public IPO plans have been announced for Sofya.

How can I track Sofya secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sofya's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Employee Range16
Year FoundedN/A
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?